FDA — authorised 13 July 1973
- Application: ANDA080951
- Marketing authorisation holder: IMPAX LABS
- Local brand name: VITAMIN D
- Indication: CAPSULE — ORAL
- Status: approved
🇺🇸 Infuvite Adult in United States
FDA authorised Infuvite Adult on 13 July 1973
Marketing authorisations
FDA — authorised 16 October 1978
- Application: ANDA080704
- Marketing authorisation holder: BIONPHARMA
- Local brand name: VITAMIN D
- Indication: CAPSULE — ORAL
- Status: approved
FDA — authorised 18 May 2000
- Marketing authorisation holder: SANDOZ
- Status: approved
FDA — authorised 18 May 2000
- Application: NDA021163
- Marketing authorisation holder: SANDOZ CANADA INC
- Local brand name: INFUVITE ADULT
- Indication: SOLUTION — INTRAVENOUS
- Status: approved
FDA
- Application: ANDA080956
- Marketing authorisation holder: EVERYLIFE
- Local brand name: VITAMIN D
- Indication: CAPSULE — ORAL
- Status: approved
Infuvite Adult in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Other Metabolic approved in United States
Frequently asked questions
Is Infuvite Adult approved in United States?
Yes. FDA authorised it on 13 July 1973; FDA authorised it on 16 October 1978; FDA authorised it on 18 May 2000.
Who is the marketing authorisation holder for Infuvite Adult in United States?
IMPAX LABS holds the US marketing authorisation.